Why the alternatives question comes before the hospital question
Many overseas patients start by comparing hospitals or asking about robotic surgery. That order can lead to a decision made before the clinical question is clear. Radical prostatectomy is one treatment for prostate cancer, not the only one. Whether it is appropriate depends on the cancer's risk group, how far it appears to have spread, your age and general health, and what matters most to you.
The alternatives usually discussed for localised prostate cancer include active surveillance or monitoring, external beam radiotherapy, brachytherapy, and focal treatments such as high-intensity focused ultrasound or cryotherapy in selected cases. Hormone therapy may be used alongside radiotherapy in some situations. These are not interchangeable. Each has different demands on your time, different side-effect profiles and different follow-up requirements.
For an overseas patient, this matters practically. Surgery generally means travelling to a hospital, staying for the operation and early recovery, and arranging follow-up. Radiotherapy may involve daily treatment over several weeks. Surveillance may mean repeated testing closer to home. The right choice is a clinical decision, but the logistics differ enough that you should understand the route before you commit to travel.
What surgery involves and what it does not guarantee
Radical prostatectomy removes the prostate gland. In robotic-assisted radical prostatectomy, the surgeon controls robotic instruments rather than holding them directly. The operation is performed for selected prostate cancers, and the treating team decides whether it is suitable for a particular patient.
That last point is worth pausing on, because it shapes how you should read any hospital's marketing. A centre may perform many of these operations and still conclude that your cancer is better managed another way. The recommendation depends on your pathology, your imaging, your age, your general health and your own priorities, not on how many procedures the centre lists.
Patients often ask about cancer control, urinary continence and sexual function. These outcomes vary between individuals and depend on the cancer, the anatomy, the surgeon's experience and the patient's baseline function. No responsible clinician can promise a specific result. Instead, ask what the team's own experience is, what they will do to reduce risk, and what support is available if side effects occur.
It also helps to separate two different questions that are easy to blur. The first is whether the cancer needs treatment now. The second is whether surgery is the right way to treat it if treatment is needed. A surgeon can answer the second question well while the first still deserves a wider view, which is why the alternatives discussion belongs before you book travel.
Surgery also has its own risks, including bleeding, infection, blood clots and anaesthetic risks, as well as the functional effects mentioned above. These should be discussed with the treating surgeon, not minimised as administrative matters.
One practical consequence for an overseas patient is that the decision is not made in a single appointment. You may need your biopsy slides, imaging and PSA history reviewed before anyone can say whether an operation is appropriate. Ask what the team still needs before it can give you a clear answer, and treat that list as the real starting point for planning.
- Ask what the proposed operation involves and why it is recommended for your cancer.
- Ask how the team will assess and manage urinary and sexual function before and after surgery.
- Ask what the plan is if the pathology after surgery shows features that need further treatment.
How to compare surgery with surveillance and radiotherapy
A useful comparison starts with your risk group. Low-risk prostate cancer may be suitable for active surveillance, which means monitoring with PSA tests, examinations and repeat biopsies rather than immediate treatment. This avoids or delays the side effects of surgery or radiotherapy but requires reliable follow-up and acceptance of some uncertainty. If the cancer shows signs of progression, treatment can be reconsidered.
Radiotherapy, given externally or through brachytherapy, is another curative-intent option for many localised cancers. It is not surgery, and it has different side effects, including bowel, urinary and sexual effects. Some patients choose radiotherapy because they prefer not to have an operation; others choose surgery because they prefer to remove the gland. Neither preference is wrong, but the clinical suitability must be assessed individually.
Focal treatments aim to treat part of the prostate rather than the whole gland. They may be offered in selected cases, often within a clinical pathway that includes careful imaging and follow-up. Availability, eligibility criteria and evidence for these approaches vary. Ask the treating team whether focal treatment is a reasonable option for your cancer and what follow-up it requires.
A labelled planning example: how one patient's question changes the next step
Consider a hypothetical overseas patient, Mr A, with newly diagnosed prostate cancer. He has a biopsy report, a PSA history and an MRI report. He is otherwise healthy and wants to know whether to travel to China for surgery.
If his cancer is low-risk and his urologist considers active surveillance reasonable, the next step might be to clarify surveillance protocols and whether he can do them locally, rather than booking surgery. If his cancer is intermediate or high-risk and surgery is being considered, the next step is to confirm whether the records are complete enough for a specialist to give a meaningful opinion, and to ask what additional staging or tests the treating hospital would require.
If he is also considering radiotherapy, the next step is to ask whether a radiation oncologist should review his case alongside the surgeon. In some complex cases, a multidisciplinary review involving urology and radiation oncology can help clarify the options. This is not a second opinion for its own sake; it is a way to make sure the alternatives have been properly considered before travel.
Records that make a China consultation useful
A specialist reviewing your case from a distance needs the same core information a local urologist would use. The most useful records include your biopsy report with Gleason score or grade group, your PSA results over time, and any imaging such as MRI or bone scan. If you have had genomic testing, include that as well. A short summary of your medical history, current medicines and allergies helps the team assess surgical fitness.
You do not need to send a complete archive at first contact. A brief summary and the key reports are enough for an initial review. The team can then tell you what else is needed. If a record is missing, ask whether it is essential for the decision or whether the review can proceed with what you have.
For China specifically, ask how records should be shared, whether translation is needed, and whether the hospital requires original documents or accepts copies. These are administrative questions with hospital-specific answers, so confirm them with the provider rather than assuming a standard rule.
- Biopsy report with Gleason score or grade group
- PSA results over time
- MRI or other staging imaging reports
- List of current medicines and allergies
- Brief medical history including other conditions
Questions that change the next step
The answers to a few questions determine whether you should plan travel, seek more records, or reconsider the treatment route. Ask the treating team directly; do not rely on general information.
First, is surgery recommended for my cancer, and why? Second, what are the alternatives, and are they available and suitable for me? Third, what records or tests are missing before a decision can be made? Fourth, what does the treating hospital need from me to confirm acceptance and scheduling? Fifth, what follow-up will I need after treatment, and can any of it be done locally?
If you are considering care in China, you can start with a free initial enquiry. This is not a diagnosis or a promise of acceptance. It is a way to have your main question and available records reviewed so you can identify the relevant next step. A proxy consultation or multidisciplinary review may be offered if a records-based opinion is useful, but it is optional and not a prerequisite for every appointment.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.